Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains
- Supplementary File 1:
PDF-Document (PDF, 312 KiB)
Ribeiro, L.N.d.M.; de Paula, E.; Rossi, D.A.; Monteiro, G.P.; Júnior, E.C.V.; Silva, R.R.; Franco, R.R.; Espíndola, F.S.; Goulart, L.R.; Fonseca, B.B. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains. Pharmaceutics 2020, 12, 769. https://doi.org/10.3390/pharmaceutics12080769
Ribeiro LNdM, de Paula E, Rossi DA, Monteiro GP, Júnior ECV, Silva RR, Franco RR, Espíndola FS, Goulart LR, Fonseca BB. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains. Pharmaceutics. 2020; 12(8):769. https://doi.org/10.3390/pharmaceutics12080769
Chicago/Turabian StyleRibeiro, Lígia N.d.M., Eneida de Paula, Daise A. Rossi, Guilherme P. Monteiro, Edson C.V. Júnior, Rogério R. Silva, Rodrigo R. Franco, Foued S. Espíndola, Luiz R. Goulart, and Belchiolina B. Fonseca. 2020. "Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains" Pharmaceutics 12, no. 8: 769. https://doi.org/10.3390/pharmaceutics12080769